In a 37‑year‑old man with weight loss and epigastric pain who has a 1‑mm linear non‑enhancing T1‑hypointense, T2‑hyperintense intramedullary signal from T8 to T10 that does not meet criteria for syringomyelia and no neurologic deficits, what is the appropriate next step in management?

Management of Incidental Linear T2 Hyperintense Spinal Cord Signal

In this 37-year-old man with an incidental 1-mm linear T2 hyperintense signal from T8-T10 and no neurologic deficits, clinical observation with focused neurologic follow-up is appropriate, as this finding does not meet criteria for syringomyelia and lacks features requiring immediate intervention.

Rationale for Conservative Management

Imaging Characteristics Favor Benign Etiology

• The 1-mm linear signal is too small to meet diagnostic criteria for syringomyelia, which typically requires a fluid-filled cavity of sufficient size to cause cord expansion 1, 2
• Absence of enhancement on contrast imaging effectively excludes active inflammatory, infectious, demyelinating, or neoplastic processes that would require immediate treatment 3
• The normal cord caliber and signal in the remainder of the thoracic spine argues against progressive pathology 3

Clinical Context Supports Observation

• The complete absence of neurologic deficits is the most critical factor determining management 4
• The patient's presenting symptoms (weight loss and epigastric pain) are unrelated to the spinal finding and should be investigated separately through appropriate gastrointestinal workup
• Localized, small T2 hyperintense signals extending under 3 vertebral segments (this case spans T8-T10, approximately 2-3 segments) often represent congenital variants such as central canal dilatation or benign findings that remain stable over time 4

Differential Diagnosis Considerations

What This Finding Likely Represents

• Most probable: Dilated central canal or minimal hydromyelia - a benign variant that does not progress and requires no intervention 1, 2, 4
• Possible: Gliosis or minimal myelomalacia from remote subclinical injury 5
• Less likely but excluded by imaging: Demyelinating disease (would typically show enhancement or multiple lesions) 3

What Has Been Effectively Ruled Out

• Intramedullary tumor: Excluded by absence of enhancement and lack of mass effect 3
• Active demyelination (MS, NMO, ADEM): Excluded by lack of enhancement and absence of brain lesions or clinical dissemination 3, 6
• Vascular malformation: Excluded by absence of flow voids, enhancement, or cord edema 3
• Infectious or inflammatory myelitis: Excluded by lack of enhancement 3

Recommended Follow-Up Strategy

Initial Management

• Perform a detailed neurologic examination focusing on:
  • Sensory level testing, particularly for suspended sensory loss (cape-like distribution)
  • Motor strength in all extremities with attention to hand intrinsic muscles
  • Deep tendon reflexes and pathologic reflexes (Babinski, Hoffmann signs)
  • Proprioception and vibration sense
  • Gait assessment 7

Surveillance Protocol

• Repeat neurologic examination in 6 months, then annually if stable 4
• Repeat MRI only if new neurologic symptoms develop - routine imaging surveillance is not indicated for stable, asymptomatic findings 4
• Educate the patient about warning symptoms that should prompt immediate evaluation:
  • Progressive weakness or numbness
  • Bowel or bladder dysfunction
  • Gait disturbance or balance problems
  • New pain patterns, particularly neuropathic pain 7

Evidence Supporting Conservative Approach

Natural History Data

• Localized idiopathic syringomyelia or central canal dilatation extending under 3 vertebral segments typically remains stable without neurologic deterioration over long-term follow-up (mean 10 years) 4
• Surgery is reserved for extended lesions (≥4 vertebral segments) with progressive neurologic deficits 4
• Asymptomatic or incidental findings without clear pathophysiologic mechanism (no CSF flow obstruction, no tethering, no tumor) do not warrant surgical intervention 1, 2

Guideline-Based Approach

• Contrast-enhanced MRI has already been performed and shows no enhancement, fulfilling the recommended initial diagnostic evaluation for myelopathy 3
• Additional imaging (CT myelography, MRA, angiography) is not indicated in the absence of clinical myelopathy or specific imaging findings suggesting vascular malformation or compression 3

Critical Pitfalls to Avoid

• Do not pursue surgical intervention for asymptomatic findings - there is no evidence supporting surgery for incidental syringomyelia or hydromyelia without neurologic deficits 2, 4
• Do not order routine serial MRI imaging - this leads to unnecessary healthcare costs and anxiety without changing management in stable, asymptomatic patients 4
• Do not attribute the patient's gastrointestinal symptoms to this spinal finding - the weight loss and epigastric pain require separate investigation for gastrointestinal, metabolic, or malignant etiologies
• Do not miss a thorough initial neurologic examination - subtle deficits may be present that change the risk stratification 7

When to Reconsider Diagnosis

Red Flags Requiring Repeat Imaging

• Development of any new neurologic symptoms or signs 7
• Progressive symptoms over serial examinations 4
• Discovery of systemic disease (malignancy, infection) that could involve the spinal cord 3

Alternative Diagnoses to Consider if Symptoms Develop

• If neurologic symptoms emerge, consider brain MRI to evaluate for demyelinating disease, as spinal cord lesions can be the first manifestation of MS 3, 6
• If pain develops, consider metabolic causes (B12 deficiency causing subacute combined degeneration) or paraneoplastic syndromes given the weight loss 3